Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990:26 Suppl:S48-50.
doi: 10.1007/BF00685419.

Carboplatin and ifosfamide in ovarian cancer phase II and III trials. London Gynaecological Oncology Group

E Wiltshaw  1 , T J Perren, I D Fryatt, P R Blake, P Harper, M Slevin
Affiliations
Clinical Trial

Carboplatin and ifosfamide in ovarian cancer phase II and III trials. London Gynaecological Oncology Group

E Wiltshaw et al. Cancer Chemother Pharmacol. 1990.

Abstract

Over the past few years controversy has continued as to whether alkylating agents such as cyclophosphamide or chlorambucil are as effective as cisplatin in advanced ovarian cancer. Arguments have also been put forward against the use of combination chemotherapy, which is clearly more toxic than single-agent treatment and is probably no more effective than a single-agent platinum compound except in terms of producing a higher response rate. Certainly survival is not improved.

PubMed Disclaimer

References

    1. Cancer Chemother Pharmacol. 1989;24(1):54-7 - PubMed
    1. Cancer Treat Rev. 1985 Mar;12(1):1-47 - PubMed
    1. Cancer Treat Rep. 1983 Nov;67(11):997-1000 - PubMed
    1. Cancer Chemother Pharmacol. 1982;9(3):140-7 - PubMed

Publication types

LinkOut - more resources